Article
Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial.
JAMA oncology - 1 Mar 2022
Arrieta Oscar, Zatarain-Barrón Zyanya Lucia, Turcott Jenny G, Barrón Feliciano, Yendamuri Sai, Cardona Andrés F, Rosell Rafael
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.